OQS
ULBI icon

Occudo Quantitative Strategies’s Ultralife ULBI Stock Holding History

Occudo Quantitative Strategies’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,847
Closed -$142K – 883
2025
Q2 		$142K Buy
+15,847
New +$93.9K 0.02% 555
2023
Q4 		– Sell
-18,397
Closed -$180K – 1215
2023
Q3 		$180K Buy
+18,397
New +$147K 0.02% 813

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Occudo Quantitative Strategies's ULBI Position: Q3 2025 in Review

Occudo Quantitative Strategies sold out of Ultralife (ULBI) in Q3 2025, closing a stake of 15,847 shares — an estimated $142K sold.

Occudo Quantitative Strategies first reported a position in ULBI in Q3 2023 and held it in 2 quarters. The position peaked at $180K in Q3 2023. 63 funds tracked by Wall St. Rank hold ULBI as of Q3 2025.

  • Occudo Quantitative Strategies reported no remaining Ultralife position as of Q3 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 15,847 Ultralife shares in Q3 2025, an estimated $142K.
  • Occudo Quantitative Strategies first reported a position in Ultralife in Q3 2023 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Ultralife position peaked at $180K in Q3 2023.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q3 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.